{"hands_on_practices": [{"introduction": "Effective clinical decision-making hinges on our ability to quantify and update diagnostic uncertainty. This exercise demonstrates how to apply Bayes' theorem, using likelihood ratios, to formally adjust your suspicion of septic arthritis based on a new piece of evidence—the synovial fluid analysis [@problem_id:4879032]. Mastering this skill allows you to move beyond subjective intuition and base critical treatment decisions on calculated post-test probabilities.", "problem": "A hospitalized adult presents with acute monoarthritis of the knee. The clinician synthesizes history, examination, and epidemiologic context to estimate a pretest probability of septic arthritis of $0.30$. Synovial fluid analysis reveals a White Blood Cell (WBC) count greater than $50{,}000/\\mu\\mathrm{L}$, a finding whose Positive Likelihood Ratio (LR$^{+}$) for septic arthritis is $8$ based on high-quality studies of synovial fluid diagnostics. Using Bayes’ theorem as the fundamental base, derive the patient’s post-test probability of septic arthritis after observing the synovial WBC threshold and report the numerical value. Then, based on the computed probability, briefly interpret the clinical decision implications in relation to a commonly used treatment threshold of $0.50$ for initiating immediate empiric therapy and urgent procedural intervention. Express the final probability as a decimal (no percent sign), rounded to four significant figures.", "solution": "The problem is subjected to validation before a solution is attempted.\n\n### Step 1: Extract Givens\n-   Condition: Acute monoarthritis of the knee in a hospitalized adult.\n-   Pretest probability of septic arthritis: $0.30$.\n-   Diagnostic finding: Synovial fluid White Blood Cell (WBC) count greater than $50{,}000/\\mu\\mathrm{L}$.\n-   Positive Likelihood Ratio (LR$^{+}$) for this finding: $8$.\n-   Fundamental basis for calculation: Bayes’ theorem.\n-   Required output 1: Derive the patient’s post-test probability of septic arthritis.\n-   Required output 2: Report the numerical value of the probability, rounded to four significant figures.\n-   Required output 3: Briefly interpret the clinical decision implications in relation to a treatment threshold of $0.50$.\n\n### Step 2: Validate Using Extracted Givens\n-   **Scientifically Grounded**: The problem is well-grounded in Bayesian clinical epidemiology, a standard and critical methodology in modern evidence-based medicine. The use of pretest probability, likelihood ratios, and post-test probability to update diagnostic certainty is a fundamental application of Bayes' theorem. The values provided for the pretest probability and LR$^+$ are clinically realistic for the scenario of suspected septic arthritis.\n-   **Well-Posed**: The problem is well-posed. It provides all necessary parameters—pretest probability and a likelihood ratio—to calculate the post-test probability. The question is unambiguous and has a unique, stable solution.\n-   **Objective**: The problem is stated in precise, objective, and standard clinical and statistical terminology.\n\n### Step 3: Verdict and Action\nThe problem is **valid** as it is scientifically sound, well-posed, and objective. A solution will be provided.\n\n### Solution Derivation\nThe problem requires the calculation of a post-test probability given a pretest probability and a likelihood ratio. This is a direct application of Bayes' theorem, which can be conveniently expressed in terms of odds.\n\nLet $D$ represent the event that the patient has septic arthritis.\nLet $T$ represent the positive test result, which is a synovial fluid WBC count greater than $50{,}000/\\mu\\mathrm{L}$.\n\nThe given information is:\n-   The pretest probability of septic arthritis, $P(D) = 0.30$.\n-   The positive likelihood ratio for the test, $LR^+ = 8$.\n\nThe relationship between probability and odds is given by the formula: $\\text{Odds} = \\frac{P}{1-P}$, where $P$ is the probability of the event.\n\nFirst, we convert the pretest probability into pretest odds:\n$$\n\\text{Pretest Odds}(D) = \\frac{P(D)}{1-P(D)} = \\frac{0.30}{1-0.30} = \\frac{0.30}{0.70} = \\frac{3}{7}\n$$\n\nThe odds-ratio form of Bayes' theorem states that the post-test odds are the product of the pretest odds and the likelihood ratio.\n$$\n\\text{Post-test Odds}(D|T) = \\text{Pretest Odds}(D) \\times LR^+\n$$\nSubstituting the known values:\n$$\n\\text{Post-test Odds}(D|T) = \\frac{3}{7} \\times 8 = \\frac{24}{7}\n$$\n\nNext, we convert the post-test odds back into a probability. The relationship is given by: $P = \\frac{\\text{Odds}}{1+\\text{Odds}}$.\n$$\nP(D|T) = \\frac{\\text{Post-test Odds}(D|T)}{1 + \\text{Post-test Odds}(D|T)} = \\frac{\\frac{24}{7}}{1 + \\frac{24}{7}} = \\frac{\\frac{24}{7}}{\\frac{7}{7} + \\frac{24}{7}} = \\frac{\\frac{24}{7}}{\\frac{31}{7}} = \\frac{24}{31}\n$$\n\nTo obtain the numerical value, we perform the division and round to four significant figures as requested.\n$$\nP(D|T) = \\frac{24}{31} \\approx 0.7741935...\n$$\nRounding to four significant figures, we get:\n$$\nP(D|T) \\approx 0.7742\n$$\n\nAlternatively, one can use the probability form of Bayes' theorem directly. The formula relating post-test probability to pretest probability and likelihood ratio is:\n$$\nP(D|T) = \\frac{LR^+ \\times P(D)}{LR^+ \\times P(D) + (1-P(D))}\n$$\nSubstituting the given values:\n$$\nP(D|T) = \\frac{8 \\times 0.30}{8 \\times 0.30 + (1-0.30)} = \\frac{2.4}{2.4 + 0.7} = \\frac{2.4}{3.1} = \\frac{24}{31}\n$$\nThis confirms the result obtained using the odds-ratio method.\n\n### Clinical Interpretation\nThe calculated post-test probability of septic arthritis is approximately $0.7742$. The problem specifies a commonly used treatment threshold of $0.50$ for initiating therapy. Since the post-test probability $0.7742$ is substantially greater than the treatment threshold of $0.50$, the diagnostic information has moved the patient from a state of moderate suspicion ($P(D) = 0.30$) to a state of high probability. This result strongly supports the diagnosis of septic arthritis and justifies aggressive clinical action. The correct clinical decision would be to proceed immediately with empiric intravenous antibiotic therapy and urgent surgical consultation for joint drainage and debridement to prevent sepsis and irreversible cartilage damage.", "answer": "$$\n\\boxed{0.7742}\n$$", "id": "4879032"}, {"introduction": "For complex and high-stakes conditions like vertebral osteomyelitis, the *sequence* of diagnostic and therapeutic actions is as critical as the actions themselves. This practice challenges you to construct a safe and efficient management algorithm, weighing the urgency of intervention against the need to secure a microbiologic diagnosis [@problem_id:4676993]. You will learn to adapt your strategy based on the patient's clinical stability and neurological status, a core competency in managing serious infections.", "problem": "A patient-centered algorithm must reconcile microbiologic yield with patient safety in suspected vertebral osteomyelitis (VO). A $64$-year-old man with diabetes presents with $3$ weeks of severe midline lumbar pain, subjective fevers, and night sweats. He is afebrile in clinic but reports a home temperature of $38.4\\,^{\\circ}\\mathrm{C}$. He is hemodynamically stable, denies bowel or bladder dysfunction, and has no focal weakness, but has marked midline tenderness. Laboratory tests show erythrocyte sedimentation rate (ESR) $110\\,\\mathrm{mm/h}$, C-reactive protein (CRP) $160\\,\\mathrm{mg/L}$, and white blood cell count $12.3\\times 10^{9}/\\mathrm{L}$. He took one outpatient dose of levofloxacin earlier today. Magnetic Resonance Imaging (MRI) availability is in $4$ hours. Computed Tomography (CT)-guided percutaneous disc/vertebral biopsy can be scheduled for tomorrow morning. No blood cultures have yet been collected.\n\nConstruct an algorithm that sequences blood cultures, MRI, and CT-guided biopsy while managing antibiotic timing for both (i) the current presentation (hemodynamically stable, neurologically intact) and (ii) the counterfactual scenario that the same patient had new motor weakness and hypotension on arrival. Which option best reflects a correct, evidence-based sequence that maximizes diagnostic yield without compromising safety?\n\nA. Stable: Initiate broad-spectrum empiric antibiotics immediately, then obtain MRI, and proceed to CT-guided biopsy after $48$ hours only if blood cultures are negative. Unstable or with neurologic deficits: Start antibiotics immediately before any cultures, obtain MRI when feasible, and defer biopsy until after $7$ days of therapy if no improvement.\n\nB. Stable: Obtain $2$ sets of blood cultures immediately and withhold antibiotics; perform urgent contrast-enhanced MRI to confirm and localize VO and detect epidural abscess; if MRI is consistent with VO and blood cultures grow Staphylococcus aureus (first instance spelled out) concordant with the clinical picture, proceed with targeted therapy without biopsy; if blood cultures are negative, polymicrobial, or suggest an atypical pathogen, arrange CT-guided percutaneous biopsy before starting antibiotics; if prior antibiotics were given, hold further antibiotics for $48$–$72$ hours before biopsy if clinically safe. Unstable or with neurologic deficits: Draw $2$ sets of blood cultures, start empiric antibiotics immediately without delaying for biopsy, obtain urgent MRI, and pursue surgical decompression if indicated, with intraoperative cultures or delayed percutaneous biopsy as needed.\n\nC. Stable or unstable: Always perform CT-guided biopsy first because it is faster; start empiric antibiotics immediately after biopsy; obtain MRI only after culture results to plan surgery; blood cultures are optional and often misleading.\n\nD. Stable: Skip blood cultures to avoid contamination; obtain MRI first, start empiric antibiotics in all cases immediately after MRI, and reserve CT-guided biopsy only for those who fail to improve after $7$ days. Unstable or with neurologic deficits: Same as stable, but increase antibiotic spectrum and delay biopsy until clinical stabilization.", "solution": "### Step 1: Extract Givens\n- **Patient**: A $64$-year-old man with diabetes.\n- **Symptoms**: $3$ weeks of severe midline lumbar pain, subjective fevers, and night sweats.\n- **Physical Exam**: Afebrile in clinic, but reports a home temperature of $38.4\\,^{\\circ}\\mathrm{C}$. Hemodynamically stable, no bowel/bladder dysfunction, no focal weakness, marked midline tenderness.\n- **Laboratory Data**:\n    - Erythrocyte sedimentation rate (ESR): $110\\,\\mathrm{mm/h}$\n    - C-reactive protein (CRP): $160\\,\\mathrm{mg/L}$\n    - White blood cell count (WBC): $12.3 \\times 10^9/\\mathrm{L}$\n- **Recent Medication**: One outpatient dose of levofloxacin taken earlier on the day of presentation.\n- **Imaging/Procedure Availability**:\n    - Magnetic Resonance Imaging (MRI): Available in $4$ hours.\n    - Computed Tomography (CT)-guided percutaneous biopsy: Can be scheduled for the next morning.\n- **Microbiology**: No blood cultures have been collected yet.\n- **Task**: Construct an algorithm for two scenarios: (i) the current stable presentation, and (ii) a counterfactual unstable presentation (new motor weakness and hypotension). Select the option that best reflects the correct algorithm.\n\n### Step 2: Validate Using Extracted Givens\n1.  **Scientific Grounding**: The problem presents a classic clinical scenario of suspected vertebral osteomyelitis (VO). The patient's demographics (age, diabetes), symptoms (back pain, fever), and laboratory findings (markedly elevated ESR and CRP, mild leukocytosis) are highly consistent with this diagnosis. The management dilemmas presented—timing of cultures, imaging, biopsy, and antibiotics—are central to the real-world, evidence-based care of this condition. The problem is firmly grounded in the principles of infectious diseases and orthopedic surgery.\n2.  **Well-Posed**: The problem is well-posed. It asks for the optimal sequence of diagnostic and therapeutic interventions, a common and critical question in clinical medicine. It provides two distinct clinical scenarios (stable vs. unstable) which require different management pathways, forcing a nuanced answer. The existence of a \"best\" option is predicated on established clinical practice guidelines (e.g., from the Infectious Diseases Society of America, IDSA), which provide a framework for balancing diagnostic yield and patient safety.\n3.  **Objective**: The presentation is objective, using standard clinical and laboratory terminology. It avoids subjective or opinion-based language.\n4.  **Completeness and Consistency**: The problem provides sufficient information to make a reasoned clinical judgment. Key decision-making variables such as hemodynamic stability and neurological status are explicitly stated. The information is internally consistent.\n5.  **Realism**: The scenario and the available options are realistic. The timelines for imaging and procedures are plausible in a hospital setting. The detail about a prior dose of antibiotics is a common and important real-world challenge.\n\n### Step 3: Verdict and Action\nThe problem statement is **valid**. It is a well-constructed, scientifically sound clinical case problem that can be solved by applying established principles of infectious disease management.\n\n### Derivation of the Correct Algorithm\nThe management of suspected vertebral osteomyelitis is guided by two primary principles:\n1.  **Obtain a microbiologic diagnosis whenever possible before initiating antimicrobial therapy.** This allows for targeted, definitive therapy, which is more effective and has fewer side effects than prolonged broad-spectrum empiric therapy.\n2.  **Promptly initiate empiric therapy and/or surgical intervention in cases of hemodynamic instability or neurologic compromise.** In these emergency situations, the risk of death or permanent disability outweighs the benefit of delaying treatment for a definitive diagnosis.\n\n**Scenario (i): Stable Patient (Current Presentation)**\nThe patient is hemodynamically stable and neurologically intact. There is no immediate threat to life or spinal cord function. Therefore, the priority is to maximize diagnostic yield.\n1.  **Cultures First**: The first step should be to obtain at least two sets of blood cultures from different venipuncture sites. Blood cultures are positive in approximately $30\\%$ to $50\\%$ of VO cases and are the least invasive diagnostic method.\n2.  **Withhold Antibiotics**: Since the patient is stable, antibiotics should be withheld to avoid sterilizing the blood and tissue, which would drastically reduce the yield of cultures. The patient's single dose of levofloxacin is a concern; standard practice, if clinically safe, would be to wait $48$–$72$ hours after the last dose before performing an invasive biopsy to maximize yield.\n3.  **Urgent Imaging**: An MRI of the spine with and without contrast is the imaging modality of choice. It should be performed urgently to confirm the diagnosis, define the extent of the infection, and, crucially, to rule out an occult spinal epidural abscess (SEA), which would change management.\n4.  **Decision Point**:\n    - If blood cultures grow a pathogen consistent with the clinical picture (e.g., *Staphylococcus aureus*) and the MRI findings are classic for VO without a drainable abscess, a biopsy may be deferred, and targeted antibiotic therapy can be initiated.\n    - If blood cultures are negative, polymicrobial, or grow a contaminant, a CT-guided percutaneous biopsy is necessary to obtain tissue for culture and histopathology. This should be performed, if possible, before starting antibiotics.\n5.  **Initiate Therapy**: Antibiotics are started after the diagnostic pathway is complete (or after blood cultures, if the patient were to destabilize).\n\n**Scenario (ii): Unstable or Neurologically Compromised Patient (Counterfactual)**\nThis is a medical and potential surgical emergency. The priorities shift from diagnosis to immediate intervention.\n1.  **Cultures and Antibiotics**: Immediately draw 2 sets of blood cultures. Then, without any delay for imaging or biopsy, initiate empiric broad-spectrum intravenous antibiotics that cover common pathogens, including methicillin-resistant *S. aureus* (MRSA) and gram-negative rods.\n2.  **Urgent Imaging and Consultation**: Obtain an emergent MRI to identify cord compression, such as from an SEA, that may require surgical intervention. An immediate neurosurgical or orthopedic spine surgery consultation is mandatory.\n3.  **Source Control/Definitive Diagnosis**: If the MRI shows a significant SEA with neurological compromise, emergent surgical decompression and debridement are indicated. Cultures obtained during surgery provide the definitive microbiologic diagnosis. If surgery is not performed, a percutaneous biopsy may be considered later once the patient is stabilized, but it does not take precedence over life-saving therapy.\n\n### Evaluation of Options\n\n**A. Stable: Initiate broad-spectrum empiric antibiotics immediately, then obtain MRI, and proceed to CT-guided biopsy after $48$ hours only if blood cultures are negative. Unstable or with neurologic deficits: Start antibiotics immediately before any cultures, obtain MRI when feasible, and defer biopsy until after $7$ days of therapy if no improvement.**\n- **Stable**: The immediate initiation of antibiotics in a stable patient is incorrect. It compromises the diagnostic yield of both blood and tissue cultures.\n- **Unstable**: Starting antibiotics *before* any cultures is incorrect. Blood cultures can be drawn in minutes and should always precede the first dose of antibiotics, even in an emergency.\n- **Verdict**: **Incorrect**.\n\n**B. Stable: Obtain $2$ sets of blood cultures immediately and withhold antibiotics; perform urgent contrast-enhanced MRI to confirm and localize VO and detect epidural abscess; if MRI is consistent with VO and blood cultures grow *Staphylococcus aureus*... proceed with targeted therapy without biopsy; if blood cultures are negative... arrange CT-guided percutaneous biopsy before starting antibiotics; if prior antibiotics were given, hold further antibiotics for $48$–$72$ hours before biopsy if clinically safe. Unstable or with neurologic deficits: Draw $2$ sets of blood cultures, start empiric antibiotics immediately without delaying for biopsy, obtain urgent MRI, and pursue surgical decompression if indicated, with intraoperative cultures...**\n- **Stable**: This sequence is perfectly aligned with the derived correct algorithm. It correctly prioritizes cultures before antibiotics, uses the appropriate imaging (MRI), and provides a correct decision tree for proceeding to biopsy. It also correctly addresses the nuance of prior antibiotic use.\n- **Unstable**: This sequence is also correct. It prioritizes patient stability and preservation of neurologic function by recommending immediate cultures followed by immediate antibiotics, urgent MRI, and surgical consultation.\n- **Verdict**: **Correct**.\n\n**C. Stable or unstable: Always perform CT-guided biopsy first because it is faster; start empiric antibiotics immediately after biopsy; obtain MRI only after culture results to plan surgery; blood cultures are optional and often misleading.**\n- This option is flawed in multiple ways. A biopsy is not faster than blood cultures. MRI is essential for the initial diagnosis and to guide the biopsy; delaying it is incorrect. For an unstable patient, antibiotics cannot be delayed for a biopsy. Stating that blood cultures are \"optional and often misleading\" is dangerously wrong; they are a fundamental, non-invasive diagnostic tool.\n- **Verdict**: **Incorrect**.\n\n**D. Stable: Skip blood cultures to avoid contamination; obtain MRI first, start empiric antibiotics in all cases immediately after MRI, and reserve CT-guided biopsy only for those who fail to improve after $7$ days. Unstable or with neurologic deficits: Same as stable, but increase antibiotic spectrum and delay biopsy until clinical stabilization.**\n- **Stable**: Skipping blood cultures is incorrect and discards a valuable diagnostic opportunity. Starting empiric antibiotics in all cases after MRI is also incorrect for a stable patient, as it prevents a targeted approach. Delaying biopsy until clinical failure significantly reduces its yield and delays proper treatment.\n- **Unstable**: The \"same as stable\" approach is fundamentally wrong, as the management priorities are entirely different.\n- **Verdict**: **Incorrect**.", "answer": "$$\\boxed{B}$$", "id": "4676993"}, {"introduction": "Modern antimicrobial stewardship requires precision, especially for challenging infections treated with drugs that have a narrow therapeutic index. For serious MRSA osteomyelitis, successful outcomes depend on achieving specific pharmacokinetic/pharmacodynamic (PK/PD) targets, such as a goal $AUC_{24}/MIC$ ratio. This problem provides a hands-on opportunity to translate this advanced therapeutic principle into a practical, patient-specific vancomycin dosing regimen based on individual renal function and body weight [@problem_id:4677038].", "problem": "A hospitalized adult with biopsy-proven methicillin-resistant Staphylococcus aureus (MRSA) vertebral osteomyelitis is to receive intravenous vancomycin. The microbiology laboratory reports a minimum inhibitory concentration (MIC) by broth microdilution of $1\\,\\text{mg}/\\text{L}$. Therapeutic drug monitoring targets for serious MRSA infections recommend an area under the concentration–time curve over $24$ hours to MIC ratio $\\left(AUC_{24}/MIC\\right)$ between $400$ and $600$. Assume steady-state, linear pharmacokinetics, and complete bioavailability for intravenous administration.\n\nUsing only the following foundational facts:\n- By definition of clearance in linear pharmacokinetics, for a dose administered over a $24$ hour period, $$AUC_{24}=\\frac{\\text{Dose over }24\\,\\text{h}}{CL},$$ where $CL$ is systemic clearance.\n- For vancomycin in adults, systemic clearance is predominantly renal and is approximately proportional to creatinine clearance (CrCl): $$CL_{\\text{vanco}}=\\theta \\cdot CrCl_{\\text{(in L/h)}},$$ with proportionality constant $\\theta=0.75$.\n- Estimate creatinine clearance (CrCl) using the Cockcroft–Gault equation: $$CrCl_{\\text{(in mL/min)}}=\\frac{(140-\\text{age in years})\\cdot \\text{weight in kg}\\cdot \\phi}{72\\cdot S_{Cr}},$$ where $\\phi=1.00$ for males and $\\phi=0.85$ for females, and $S_{Cr}$ is serum creatinine in $\\text{mg}/\\text{dL}$. Convert $\\text{mL}/\\text{min}$ to $\\text{L}/\\text{h}$ by multiplying by $0.06$.\n\nPatient data: male, age $62$ years, total body weight $85\\,\\text{kg}$, height $178\\,\\text{cm}$, and serum creatinine $S_{Cr}=1.2\\,\\text{mg}/\\text{dL}$. For this problem, use total body weight in the Cockcroft–Gault calculation.\n\nDerive, from the above definitions and relationships, the total vancomycin maintenance dose to be administered over $24$ hours (in $\\text{mg}$ per $24$ hours) that achieves the midpoint of the recommended $AUC_{24}/MIC$ range for this patient against the reported MRSA MIC. Round your final answer to three significant figures and express it in $\\text{mg}$ per $24$ hours.", "solution": "The problem statement is first subjected to a rigorous validation process.\n\n### Step 1: Extract Givens\n- **Infection and Drug**: Methicillin-resistant Staphylococcus aureus (MRSA) vertebral osteomyelitis, treated with intravenous vancomycin.\n- **MIC**: Minimum inhibitory concentration by broth microdilution is $1\\,\\text{mg}/\\text{L}$.\n- **Therapeutic Target**: Area under the concentration–time curve over $24$ hours to MIC ratio ($AUC_{24}/MIC$) between $400$ and $600$.\n- **Pharmacokinetic Assumptions**: Steady-state, linear pharmacokinetics, complete bioavailability for intravenous administration.\n- **Formulas Provided**:\n    1. $AUC_{24}=\\frac{\\text{Dose over }24\\,\\text{h}}{CL}$\n    2. $CL_{\\text{vanco}}=\\theta \\cdot CrCl_{\\text{(in L/h)}}$, with $\\theta=0.75$.\n    3. $CrCl_{\\text{(in mL/min)}}=\\frac{(140-\\text{age in years})\\cdot \\text{weight in kg}\\cdot \\phi}{72\\cdot S_{Cr}}$, with $\\phi=1.00$ for males and $\\phi=0.85$ for females.\n- **Conversion Factor**: To convert $CrCl$ from $\\text{mL}/\\text{min}$ to $\\text{L}/\\text{h}$, multiply by $0.06$.\n- **Patient Data**: male, age $62$ years, total body weight $85\\,\\text{kg}$, height $178\\,\\text{cm}$, and serum creatinine $S_{Cr}=1.2\\,\\text{mg}/\\text{dL}$.\n- **Instruction**: Use total body weight in the Cockcroft–Gault calculation.\n- **Objective**: Derive the total vancomycin maintenance dose over $24$ hours (in $\\text{mg}$) that achieves the midpoint of the recommended $AUC_{24}/MIC$ range. Round the final answer to three significant figures.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is a standard, well-defined clinical pharmacokinetics calculation.\n- **Scientifically Grounded (Critical)**: The problem is based on established principles of pharmacokinetics and widely used clinical formulas (Cockcroft-Gault equation) and therapeutic drug monitoring targets for vancomycin. All premises are scientifically sound.\n- **Well-Posed**: The problem provides all necessary data and equations to calculate a unique solution. The question is clear and unambiguous.\n- **Objective (Critical)**: The problem is stated using precise, objective, and quantitative language. It is free of subjective or opinion-based claims.\n- **Completeness and Consistency**: The givens are self-contained and consistent. There are no missing data points or contradictory constraints. The use of total body weight is explicitly specified, removing ambiguity.\n- **Feasibility**: The patient data and parameters are all within realistic clinical ranges. The calculations required are standard and feasible.\n\n### Step 3: Verdict and Action\nThe problem is deemed **valid**. A complete, reasoned solution will be provided.\n\nThe objective is to calculate the total daily maintenance dose of vancomycin required to achieve a specific therapeutic target for this patient. The derivation proceeds in three main steps: determining the target Area Under the Curve ($AUC_{24}$), calculating the patient's drug clearance ($CL$), and finally, computing the required dose.\n\n**Step 1: Determine the Target $AUC_{24}$**\n\nThe recommended therapeutic range for the ratio of the area under the concentration-time curve over $24$ hours to the minimum inhibitory concentration, $AUC_{24}/MIC$, is given as $400$ to $600$. The problem specifies targeting the midpoint of this range.\n\nThe midpoint is calculated as:\n$$ \\text{Target } \\frac{AUC_{24}}{MIC} = \\frac{400 + 600}{2} = 500 $$\nThe units for this ratio are conventionally understood to be $(\\text{mg}\\cdot\\text{h}/\\text{L}) / (\\text{mg}/\\text{L}) = \\text{h}$.\n\nThe reported MIC for the MRSA strain is $1\\,\\text{mg}/\\text{L}$. We can now calculate the target $AUC_{24}$:\n$$ \\text{Target } AUC_{24} = \\left(\\text{Target } \\frac{AUC_{24}}{MIC}\\right) \\times MIC $$\n$$ \\text{Target } AUC_{24} = 500 \\times 1\\,\\frac{\\text{mg}}{\\text{L}} = 500\\,\\frac{\\text{mg}\\cdot\\text{h}}{\\text{L}} $$\n\n**Step 2: Calculate the Patient's Vancomycin Clearance ($CL_{\\text{vanco}}$)**\n\nVancomycin clearance is proportional to creatinine clearance ($CrCl$). We must first estimate the patient's $CrCl$ using the Cockcroft-Gault equation.\n\nThe provided patient data are:\n- Age: $62$ years\n- Total body weight: $85\\,\\text{kg}$\n- Sex: Male, so the correction factor $\\phi = 1.00$\n- Serum creatinine ($S_{Cr}$): $1.2\\,\\text{mg}/\\text{dL}$\n\nThe Cockcroft-Gault equation is:\n$$ CrCl_{\\text{(in mL/min)}}=\\frac{(140-\\text{age})\\cdot \\text{weight}\\cdot \\phi}{72\\cdot S_{Cr}} $$\nSubstituting the patient's data:\n$$ CrCl = \\frac{(140 - 62) \\cdot 85 \\cdot 1.00}{72 \\cdot 1.2} = \\frac{78 \\cdot 85}{86.4} = \\frac{6630}{86.4} \\approx 76.744\\,\\frac{\\text{mL}}{\\text{min}} $$\n\nNext, we convert $CrCl$ from units of $\\text{mL}/\\text{min}$ to $\\text{L}/\\text{h}$ using the given conversion factor of $0.06$:\n$$ CrCl_{\\text{(in L/h)}} \\approx 76.744\\,\\frac{\\text{mL}}{\\text{min}} \\times 0.06\\,\\frac{\\text{L}/\\text{h}}{\\text{mL}/\\text{min}} \\approx 4.6046\\,\\frac{\\text{L}}{\\text{h}} $$\n\nNow, we can calculate the systemic vancomycin clearance ($CL_{\\text{vanco}}$) using the provided relationship:\n$$ CL_{\\text{vanco}}=\\theta \\cdot CrCl_{\\text{(in L/h)}} $$\nWith the proportionality constant $\\theta = 0.75$:\n$$ CL_{\\text{vanco}} = 0.75 \\cdot 4.6046\\,\\frac{\\text{L}}{\\text{h}} \\approx 3.4535\\,\\frac{\\text{L}}{\\text{h}} $$\n\n**Step 3: Calculate the Total Daily Dose**\n\nThe problem provides the fundamental pharmacokinetic relationship between dose, $AUC_{24}$, and clearance:\n$$ AUC_{24} = \\frac{\\text{Dose over }24\\,\\text{h}}{CL} $$\nRearranging to solve for the dose:\n$$ \\text{Dose over }24\\,\\text{h} = AUC_{24} \\times CL $$\nUsing the target $AUC_{24}$ from Step 1 and the calculated $CL_{\\text{vanco}}$ from Step 2:\n$$ \\text{Dose over }24\\,\\text{h} \\approx 500\\,\\frac{\\text{mg}\\cdot\\text{h}}{\\text{L}} \\times 3.4535\\,\\frac{\\text{L}}{\\text{h}} \\approx 1726.75\\,\\text{mg} $$\n\n**Step 4: Final Rounding**\n\nThe problem requires the final answer to be rounded to three significant figures.\nThe calculated dose is approximately $1726.75\\,\\text{mg}$. The first three significant digits are $1$, $7$, and $2$. The fourth digit is $6$, which is greater than or equal to $5$, so we round up the third digit.\n$$ \\text{Dose} \\approx 1730\\,\\text{mg per } 24\\,\\text{hours} $$\nThis dose would be administered over a $24$-hour period, typically as divided doses (e.g., $865\\,\\text{mg}$ every $12$ hours). The question asks for the total dose over $24$ hours.", "answer": "$$\\boxed{1730}$$", "id": "4677038"}]}